Theravance Biopharma, Inc. 2025 Q3 – Results – Earnings Call Presentation (NASDAQ:TBPH) 2025-11-11
Q3: 2025-11-10 Earnings AbstractEPS of $0.04 beats by $0.09 Â |Â Income of $19.99M (18.51% Y/Y) beats by $96.50KThis text was written ...
Tag: Theravance
Get the latest financial news, expert analysis, and in-depth reports from The Financial Observer. Stay ahead in the world of finance with up-to-date trends, market insights, and more.